Journal of Computer-Aided Molecular Design

Papers
(The TQCC of Journal of Computer-Aided Molecular Design is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Computational investigation of functional water molecules in GPCRs bound to G protein or arrestin176
Reshaping globular dynamics of S. aureus pyruvate kinase via bond restraints to allosteric sites72
Interconversion of the (+)-O-desmethyltramadol to the lowest-energy conformer when coupled to µ-opioid receptor: comprehensive analysis using in silico molecular modeling44
GPCRLigNet: rapid screening for GPCR active ligands using machine learning28
Computational peptide discovery with a genetic programming approach25
Integrated strategy for screening direct Keap1-Nrf2 PPI inhibitors from traditional Chinese medicine: a case study of Achyranthis bidentatae Radix23
Comprehensive analysis of beta-lactamase genes in clinical strains of Escherichia coli and Klebsiella pneumoniae: molecular characterization, and in Silico predictions22
QM assisted ML for 19F NMR chemical shift prediction21
Enhancing sampling of water rehydration upon ligand binding using variants of grand canonical Monte Carlo20
Comprehensive evaluation of end-point free energy techniques in carboxylated-pillar[6]arene host–guest binding: II. regression and dielectric constant20
Obtaining QM/MM binding free energies in the SAMPL8 drugs of abuse challenge: indirect approaches19
A high quality, industrial data set for binding affinity prediction: performance comparison in different early drug discovery scenarios18
GADRC: a graph-based approach for drug repositioning with deep residual networks and computational feature-guided undersampling18
PoseEdit: enhanced ligand binding mode communication by interactive 2D diagrams18
In silico exploration of natural xanthone derivatives as potential inhibitors of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and cellular entry18
COSMO-RS blind prediction of distribution coefficients and aqueous pKa values from the SAMPL8 challenge16
FastGrow: on-the-fly growing and its application to DYRK1A16
Evolution of Support Vector Machine and Regression Modeling in Chemoinformatics and Drug Discovery16
Exploring the toxicity of fluoxastrobin: a combined computational and experimental approach15
Predicting drug-target affinity through triple pre-activated random residual planet convolution coupled attention network and contact maps15
Computational investigation on the properties of alkoxysilyl-anchored near-infrared porphyrin dyes for application in dye-sensitized solar cells14
Design, synthesis, pharmacological evaluation and computational modeling of 4-formyl-2-nitrophenyl quinoline-8-sulfonate derived thiosemicarbazones as antidiabetic agents13
“Heptadecanol” a phytochemical multi-target inhibitor of SMYD3 & GFPT2 proteins in non-small cell lung cancer: an in-silico & in-vitro investigation12
pH-dependent solubility prediction for optimized drug absorption and compound uptake by plants12
Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments11
Correction to: Conformational energies of reference organic molecules: benchmarking of common efficient computational methods against coupled cluster theory11
Computational design and experimental confirmation of a disulfide-stapled YAP helixα1-trap derived from TEAD4 helical hairpin to selectively capture YAP α1-helix with potent antitumor activity11
Unveiling a novel ellagic acid derivative as a potent lipoxygenase (LOX) inhibitor: integration of computational modeling and experimental validation10
In silico development of RNA aptamer candidates against thyroid receptor10
Design, synthesis, evaluation and molecular modeling of quinazoline derivatives bearing amino acids as small-molecule PD-L1 inhibitors10
Kideraspa: designing variants of staphylococcal protein a based on a diffusion model with kidera factors10
The FMO2 analysis of the ligand-receptor binding energy: the Biscarbene-Gold(I)/DNA G-Quadruplex case study10
Mechanistic insights into PROTAC-mediated degradation through an integrated framework of molecular dynamics, free energy landscapes, and quantum mechanics: A case study on kinase degraders9
User-centric design of a 3D search interface for protein-ligand complexes9
Binding free energies for the SAMPL8 CB8 “Drugs of Abuse” challenge from umbrella sampling combined with Hamiltonian replica exchange9
Breast cancer diagnosis from histopathological images and molecular signatures by fusing features with an explainable AI-based residual tabular network model9
Evaluating computational and experimental approaches in early-stage Alzheimer’s drug discovery: a systematic review9
An overview of the SAMPL8 host–guest binding challenge9
Improving drug discovery with a hybrid deep generative model using reinforcement learning trained on a Bayesian docking approximation9
De novo drug design through gradient-based regularized search in information-theoretically controlled latent space8
Enhancing molecular representation via fusion of multimodal transformers with integrated periodic local and global features8
Integrated machine learning and deep learning-based virtual screening framework identifies novel natural GSK-3β inhibitors for Alzheimer’s disease8
Improvement of multi-task learning by data enrichment: application for drug discovery8
Contact networks in RNA: a structural bioinformatics study with a new tool8
Protein-ligand co-design: a case for improving binding affinity between type II NADH:quinone oxidoreductase and quinones8
Advanced investigation of the adsorption process of geosmin molecules on polar bear and camel olfactory receptors: statistical physics treatment, in-depth DFT-modeling, and docking analysis8
Modeling receptor flexibility in the structure-based design of KRASG12C inhibitors8
Cytotoxic and gene expression effects of deltamethrin and acetamiprid on MDA-MB-231 breast cancer cells: a molecular and functional study8
Antitumor evaluation of novel alizarin-based derivatives through biological and computational approaches8
Molecular dynamics insights into the interactions of biocompatible synthetic polymer composites with carbon-based nanoparticle derivatives: a comparative study of PLGA and PCL interactions with GO/rGO7
Molecular and thermodynamic insights into interfacial interactions between collagen and cellulose investigated by molecular dynamics simulation and umbrella sampling7
Molecular docking, dynamics simulations, and in vivo studies of gallic acid in adenine-induced chronic kidney disease: targeting KIM-1 and NGAL7
Multitarget neuroprotective effects of β-sitosterol in diabetes-associated neurodegeneration: a coupled experimental/computational study7
Comparison of logP and logD correction models trained with public and proprietary data sets7
From closed to open: three dynamic states of membrane-bound cytochrome P450 3A47
Combined experimental and computational investigation of vildagliptin: spectroscopy, electronic structure, MD and Docking to EGFR, VEGFR2, and HER2 anticancer targets7
Extended continuous similarity indices: theory and application for QSAR descriptor selection7
DeepCubist: Molecular Generator for Designing Peptidomimetics based on Complex three-dimensional scaffolds7
Exploring Oxazolidinone scaffolds for future antibiotics: synthesis and computational insights with DFT, docking, ADME and MD simulation7
Benchmarking ANI potentials as a rescoring function and screening FDA drugs for SARS-CoV-2 Mpro7
Molecular dynamics simulations reveal the inhibition mechanism of Cdc42 by RhoGDI16
Discovery of novel natural product-derived EGFR inhibitors using multiple linear regression, stacked ensemble regression, and fingerprinting approaches6
Mycobacterium tuberculosis FAS-II pathway targeted integrative deep learning based identification of potential anti-tubercular agents6
Artificial intelligence in protein-based detection and inhibition of AMR pathways6
Reliable gas-phase tautomer equilibria of drug-like molecule scaffolds and the issue of continuum solvation6
CoBdock-2: enhancing blind docking performance through hybrid feature selection combining ensemble and multimodel feature selection approaches6
Enhancing accuracy of virtual kinase profiling via application of graph neural network to 3D pharmacophore ensembles6
Multi-Omics Analysis of the virulence factors and designing of next-generation multi-epitopes Vaccines against Rickettsia prowazekii: a computer-aided vaccine designing approach6
Targeting neurodegeneration: three machine learning methods for G9a inhibitors discovery using PubChem and scikit-learn6
Structure-based identification and experimental evaluation of Oroxin A as a FYN kinase inhibitor6
Comparative assessment of physics-based in silico methods to calculate relative solubilities5
Exploring the anti-diabetic potential of the Vigna sesquipedalis using in vitro, in vivo and computational models5
Correction to: Computational workflow for discovering small molecular binders for shallow binding sites by integrating molecular dynamics simulation, pharmacophore modeling, and machine learning: STAT5
Multi-scale in-silico modelling to unveil structural requirements for DNA-PK inhibitors as radiosensitizers and MolSHAP based design of novel ligands5
Steered molecular dynamics simulation as a post-process to optimize the iBRAB-designed Fab model5
From mundane to surprising nonadditivity: drivers and impact on ML models5
Development of human lactate dehydrogenase a inhibitors: high-throughput screening, molecular dynamics simulation and enzyme activity assay5
Exploring DrugCentral: from molecular structures to clinical effects5
In silico design of dehydrophenylalanine containing peptide activators of glucokinase using pharmacophore modelling, molecular dynamics and machine learning: implications in type 2 diabetes5
On the construction of LIECE models for the serotonin receptor 5-HT$$_{\text {2A}}$$R5
MDFit: automated molecular simulations workflow enables high throughput assessment of ligands-protein dynamics5
0.090687036514282